Brief update clascoterone phase 3 - Breezula
    Research/Science 3/20/2024

    At a glance
    In this general discussion post, the primary subjects mentioned are the tone is 😐 neutral.

    Other terms

    Cosmo Pharmaceuticals has enrolled about 850 out of 1400 patients for their phase 3 clinical trials of clascoterone (Breezula) and claims to be on schedule. The conversation is about hair loss treatments.
    View this post in the Community →

    Similar Community Posts Join

    5 / 111 results

    Related Research

    6 / 63 results